Index  ›  health  ›  Medical News Today

Will Zepbound get cheaper? Ways to lower your costs now

Medical News Today Published Jun 8, 2026 Reviewed Jun 30, 2026 ✓ Reviewed by citations.press editors
Citation-ready fact
The Zepbound Savings Card can reduce out‑of‑pocket cost to as low as $25 for a 3‑month prescription for those with commercial insurance coverage.
25 $ · out-of-pocket cost
Eli Lilly, manufacturer
View source ↗
Citation-ready fact
An authorized generic version of Zepbound will not be available until at least the 2030s due to active patents held by the manufacturer.
at least 2030 year · generic availability
Eli Lilly, manufacturer
View source ↗
Citation-ready fact
Commercial insurance coverage for weight management medications has slowly expanded throughout 2026.
2026 year · insurance coverage expansion
View source ↗

The out-of-pocket cost for Zepbound is expected to decrease for many people over time. While the official list price of the brand-name medication may not drop immediately, your actual monthly costs can drop through expanding insurance coverage, manufacturer savings programs, and increasing market competition.

If you want to save money on your prescription right now, you have a few actionable options. First, the drug’s manufacturer, Eli Lilly, offers a Zepbound Savings Card. This card works with or without insurance coverage, though savings are typically higher when used with a qualifying insurance plan.

If you have commercial insurance that covers the medication, this card can bring your out-of-pocket cost as low as $25 for a 3-month prescription. If you don’t use insurance or choose to self-pay, a third-party savings program may still help lower your out-of-pocket costs.

Additionally, throughout 2026, commercial insurance coverage for weight management medications has slowly expanded. Review your plan’s formulary to see whether Zepbound is a covered drug and find out what prior authorization steps you may need to take.

If you need help navigating this process, read our comprehensive guide on insurance coverage with Zepbound.

An authorized generic version of Zepbound (tirzepatide) will not be available for several years. The manufacturer holds active patents that prevent other companies from producing a true generic until at least the 2030s. However, as new GLP-1 and GIP medications are developed and enter the market, this increased competition could eventually drive prices down across the entire class of weight management drugs.

A note on compounded tirzepatide: You may see “compounded tirzepatide” advertised online at much lower prices. Compounded formulas are not the same as generic Zepbound. They do not have the same rigorous testing, safety guarantees, or oversight from the Food and Drug Administration (FDA) as the brand-name drug or future authorized generics.

To explore other safe, FDA-approved options that might fit your budget, read about weight loss drugs covered by insurance in 2026.

Disclaimer: While Medical News Today strives for factual, comprehensive, and current information, this article is not a substitute for a licensed healthcare professional’s expertise. Always consult a doctor before taking or discontinuing any medication. Drug information is subject to change and may not cover all uses, directions, precautions, warnings, interactions, reactions, or adverse effects. The lack of a warning does not guarantee a drug’s safety, effectiveness, or appropriateness for all patients or specific uses. Learn more about our approach to content integrity.

This article was originally published by Medical News Today ↗. citations.press indexes the source-backed facts above and links to the original. Something wrong? Corrections policy · Report an error